Most self-pay patients are either uninsured or have a health plan that does not cover obesity medications like Wegovy
To view or add a comment, sign in More Relevant Posts Evidence of therapeutic potential of GLP-1RAs in autoimmune and autoinflammatory diseases, including psoriasis, inflammatory bowel diseases, rheumatoid arthritis, asthma, multiple sclerosis, Sjgrens syndrome, and systemic lupus erythematosus
As it was recently suggested, GSH depletion could be the Trojan horse of COVID-19 severity and mortality and elevating GSH levels in tissues may decrease COVID-19 severity and mortality rates (Khanfar and Al Qaroot, 2020)
World Obesity Atlas 2023 (World Obesity Federation, 2023)
Around 68% of patients show improved glycemic control using these therapies, while 59% experience weight reduction exceeding 5% body mass